Avandia
Jump to navigation
Jump to search
Avandia (generic name rosiglitazone) is a drug manufactured by GlaxoSmithKline for the treatment of type 2 diabetes.
Websites
- GSK consumer website: http://www.avandia.com/
- GSK website for media on Avandia http://gsk.com/media/avandia-press-kit.htm
Resources
References
Related SourceWatch Articles
External links
- U.S. Food and Drug Administration, "FDA Issues Safety Alert on Avandia", Media Release, May 21, 2007.
| This article is a stub. You can help by expanding it. |
